Pfizer's former R&D chief Dolsten pulls out of Novo Nordisk board race
Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday.
November 13, 2025
Florida wildfire strands Amtrak passengers for over 24 hours
New play looks to explain how the U.S. Constitution plays a role in daily life
New York sues Coinbase and Gemini, seeking to halt unlicensed prediction market businesses
Small business owners skeptical about getting tariff refunds
Maradona’s daughter assails doctor in negligence trial over soccer great's death
Internal documents shed light on Trump’s crusade to vet state voter rolls
Stray dog search prompts Blue Ridge Parkway closures, draws welfare concerns